Important Updates Page

02/27/12

RISPERDAL CONSTA (risperidone) Long-Acting Injection Dear Healthcare Professional Letter

RISPERDAL CONSTA DHCP Letter February 2012

02/24/12

LEVAQUIN (levofloxacin) Dear Healthcare Professional Letter

LEVAQUIN DHCP Letter February 2012

01/03/12

DORIBAX (doripenem for injection) Dear Healthcare Professional Letter

DORIBAX DHCP Letter January 3, 2012

12/12/11

Oncology - DOXIL® (doxorubicin HCl liposome injection) – Supply Shortage Update

Doxil DHCP Letter 12/12/11

11/21/11

Oncology - DOXIL® (doxorubicin HCl liposome injection) – Supply Shortage Update

Doxil DHCP Letter 11/21/11

06/24/11

Oncology/Nephrology - PROCRIT® (epoetin alfa) - ESA label update

PROCRIT ESA Letter 6/24/2011

06/21/11

Oncology - DOXIL® (doxorubicin HCl liposome injection) – Availability

Doxil DHCP Letter 6/21/11

06/16/11

Psychiatry – RISPERDAL® (risperidone)/Risperidone - Recall

Risperdal - Risperidone Recall Letter 06/16/11

04/11/11

Oncology/Nephrology – PROCRIT®(epoetin alfa) - Recall

Procrit DHCP Letter 4Apr 11

03/01/11

Psychiatry - Antipsychotic Class Labeling Change: New Safety Information Regarding Use During Pregnancy

Risperidone – Paliperidone Dear Healthcare Provider Letter 1Mar11

Haloperidol DHCP Letter 1Mar11

02/16/11

Psychiatry - INVEGA SUSTENNA®(paliperidone palmitate) 234 mg Syringe Recall

Invega Sustenna Recall with PI

02/01/11

ORTHOCLONE OKT3®(muromonab-CD3)

Dear Healthcare Professional letter